Skip to main content
Screener/Healthcare/Biotechnology

CRNX — Crinetics Pharmaceuticals, Inc.

NASDAQ
$37.08-6.41 (-14.74%)
Mid CapUnder $50HealthcareFastest GrowingLow Beta
$25.83
$57.99
$36.73
$43.31
EPS (TTM)$-5.14
P/E Ratio-7.71
Dividend Yield—
Market Cap$4.09B
Volume3.96M
Prev Close$43.49
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$10.7M-$127.8M$-1.2398.1%-1191.0%
Q4 '25$3.9M-$122.8M$-1.30111.8%-3161.3%
Q3 '25$143K-$130.1M$-1.38100.0%-90972.7%
Q2 '25$1.0M-$115.6M$-1.23100.0%-11216.0%
Q1 '25$361K-$96.8M$-1.04100.0%-26807.2%
Q4 '24$0-$80.6M$-0.88——
Q3 '24$0-$76.8M$-0.96——
Q2 '24$399K-$74.1M$-0.94100.0%-18560.2%
Get Your Daily Market Recap